Inactive Instrument
HedgePath Pharmaceuticals Inc Stock
Stocks
US42278K1025
Biotechnology & Medical Research
| 1 day | -27.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 76 | 2022-12-12 |
James McNulty
DFI | Director of Finance/CFO | 75 | 2022-12-12 |
Simon Bettink
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frank O'Donnell
CHM | Chairman | 76 | 2022-12-12 |
Niraj Vasisht
BRD | Director/Board Member | 63 | 2022-12-12 |
Samuel Sears
BRD | Director/Board Member | 82 | 2013-08-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -27.42% | -3.08% | - | - | 32.23M | ||
| +1.52% | +2.87% | -9.34% | -4.00% | 43.24B | ||
| +1.73% | +3.59% | +318.08% | +564.04% | 35.25B | ||
| +0.61% | +1.34% | +10.00% | +46.20% | 30.22B | ||
| +0.02% | -5.93% | +8.45% | -21.44% | 28.01B | ||
| -1.06% | -3.71% | +9.08% | +19.56% | 24.08B | ||
| -1.23% | +2.11% | - | - | 14.16B | ||
| -0.99% | -2.53% | +47.29% | +102.88% | 13.01B | ||
| +1.73% | +2.87% | +8.40% | +14.03% | 12.7B | ||
| +2.39% | +2.61% | +102.86% | +84.20% | 12.54B | ||
| Average | -2.29% | -0.27% | +61.85% | +100.68% | 23.69B | |
| Weighted average by Cap. | +0.64% | -0.20% | +68.22% | +118.31% |
Employees
-
















